A MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, MULTI-ARM HISTORICAL CONTROL, COMPARATIVE TRIAL OF THE SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AND THE COMBINATION OF HYDROXYCHLOROQUINE AND FAMOTIDINE FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 DISEASE
- Funded by Biomedical Advanced Research and Development Authority (BARDA)
- Total publications:0 publications
Grant number: 75A50120C00078
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Known Financial Commitments (USD)
$20,747,018Funder
Biomedical Advanced Research and Development Authority (BARDA)Research Location
United States of AmericaLead Research Institution
ALCHEM LABORATORIES CORPORATIONResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Clinical trial (unspecified trial phase)Special Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Randomized Controlled TrialBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
A MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, MULTI-ARM HISTORICAL CONTROL, COMPARATIVE TRIAL OF THE SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AND THE COMBINATION OF HYDROXYCHLOROQUINE AND FAMOTIDINE FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 DISEASE